Watson Seeks to Market Generic Vigamox; Alcon Files Suit
April 08, 2011 at 08:50 AM EDT
Watson Pharmaceuticals confirmed Friday that its Watson Laboratories unit filed an Abbreviated New Drug Application with the FDA and is seeking approval to market a generic version of an antibiotic solution that treats bacterial conjunctivitis.